Mar Abad

742 total citations
25 papers, 483 citations indexed

About

Mar Abad is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Mar Abad has authored 25 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Mar Abad's work include Genetic factors in colorectal cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Melanoma and MAPK Pathways (3 papers). Mar Abad is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Melanoma and MAPK Pathways (3 papers). Mar Abad collaborates with scholars based in Spain, United States and China. Mar Abad's co-authors include Atanasio Pandiella, Juan Carlos Montero, Alberto Ocaña, Azucena Esparís‐Ogando, Juan Jesús Cruz, César A. Rodríguez, J. Buesa, José M.P. Freije, V. Marco and Pilar Blay and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Mar Abad

25 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mar Abad Spain 11 221 172 121 87 82 25 483
S. Curley United States 8 287 1.3× 274 1.6× 134 1.1× 51 0.6× 86 1.0× 12 606
Xiaofen Pan China 15 330 1.5× 107 0.6× 170 1.4× 38 0.4× 34 0.4× 35 706
Alessandro Villanucci Italy 14 189 0.9× 209 1.2× 128 1.1× 22 0.3× 77 0.9× 35 696
Thomas Mühlenberg Germany 15 336 1.5× 168 1.0× 279 2.3× 227 2.6× 104 1.3× 28 725
Tessa Y. S. Le Large Netherlands 15 226 1.0× 407 2.4× 116 1.0× 54 0.6× 100 1.2× 28 656
Marcela Mrhalová Czechia 15 316 1.4× 218 1.3× 144 1.2× 23 0.3× 53 0.6× 48 594
Hideaki Takasaki Japan 11 197 0.9× 380 2.2× 121 1.0× 26 0.3× 263 3.2× 35 668
Woo Sun Kwon South Korea 16 267 1.2× 401 2.3× 271 2.2× 48 0.6× 89 1.1× 51 677
Julia Ketzer Germany 9 194 0.9× 104 0.6× 216 1.8× 189 2.2× 70 0.9× 18 501
Yongping Xu China 13 377 1.7× 289 1.7× 231 1.9× 27 0.3× 87 1.1× 26 800

Countries citing papers authored by Mar Abad

Since Specialization
Citations

This map shows the geographic impact of Mar Abad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Abad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Abad more than expected).

Fields of papers citing papers by Mar Abad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Abad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Abad. The network helps show where Mar Abad may publish in the future.

Co-authorship network of co-authors of Mar Abad

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Abad. A scholar is included among the top collaborators of Mar Abad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Abad. Mar Abad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, César A., Mar Abad, José Antonio Moreno-Muñoz, et al.. (2024). PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer. Cancer Medicine. 13(17). e70101–e70101. 3 indexed citations
2.
Montero, Juan Carlos, Sofía del Carmen, Mar Abad, et al.. (2023). The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and Translational Medicine. 13(4). e1217–e1217. 7 indexed citations
3.
Carmen, Sofía del, et al.. (2023). Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications. Experimental & Molecular Medicine. 55(6). 1247–1257. 1 indexed citations
4.
Montero, Juan Carlos, Sofía del Carmen, Mar Abad, et al.. (2023). An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 200–200. 5 indexed citations
5.
Sayagués, José María, et al.. (2023). Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival. International Journal of Molecular Sciences. 24(9). 8438–8438. 1 indexed citations
6.
Briz, Óscar, et al.. (2023). Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs. Biomedicine & Pharmacotherapy. 168. 115658–115658. 3 indexed citations
7.
Lozano, Elisa, Helen Hammer, Silvia Di Giacomo, et al.. (2023). Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide. Biomedicine & Pharmacotherapy. 170. 116038–116038. 9 indexed citations
8.
Montero, Juan Carlos, et al.. (2022). Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 106–106. 13 indexed citations
9.
Corchete, Luís A., et al.. (2022). Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups. Cancers. 14(17). 4076–4076. 2 indexed citations
10.
Pérez‐Losada, Jesús, et al.. (2022). iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers. World Journal of Clinical Oncology. 13(7). 616–629. 9 indexed citations
11.
Montero-Mateos, Enrique, et al.. (2021). Endoluminal tumor implant of a colorectal cancer in an anal fistula detected by FISH techniques: a case report. Journal of Gastrointestinal Oncology. 12(2). 900–905. 2 indexed citations
12.
Carmen, Sofía del, Luís A. Corchete, María José García Sánchez, et al.. (2020). Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Scientific Reports. 10(1). 4662–4662. 15 indexed citations
13.
Al‐Abdulla, Ruba, Elisa Lozano, Rocı́o I.R. Macı́as, et al.. (2019). Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters. Biochemical Pharmacology. 171. 113682–113682. 13 indexed citations
14.
Lü, Jing, Mingxin Wen, Yurong Huang, et al.. (2013). C2ORF40suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes. Epigenetics. 8(6). 571–583. 40 indexed citations
15.
Liu, Yueyong, Shancheng Ren, Andrés Castellanos‐Martín, et al.. (2012). Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer. PLoS ONE. 7(11). e49453–e49453. 11 indexed citations
16.
17.
Álava, Enrique de, Alberto Ocaña, Mar Abad, et al.. (2007). Neuregulin Expression Modulates Clinical Response to Trastuzumab in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology. 25(19). 2656–2663. 46 indexed citations
18.
Simal, François, Albert Demonceau, Alfred F. Noels, et al.. (2000). Radical reactions catalysed by ruthenium(II) complexes with anionic carborane phosphine ligands: Kharasch addition to olefins and controlled polymerisation. Tetrahedron Letters. 41(28). 5347–5351. 46 indexed citations
19.
Abad, Mar, Juana Ciudad, Isabel Silva, et al.. (1998). DNA Aneuploidy by Flow Cytometry Is an Independent Prognostic Factor in Gastric Cancer. Analytical Cellular Pathology. 16(4). 223–231. 32 indexed citations
20.
Frutos, F.J. Ortiz de, et al.. (1995). Pilomatrixoma: A description of two cases diagnosed by fine‐needle aspiration. Diagnostic Cytopathology. 12(2). 155–157. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Curley Breakdown of academic impact, for papers by Xiaofen Pan Breakdown of academic impact, for papers by Alessandro Villanucci Breakdown of academic impact, for papers by Thomas Mühlenberg Breakdown of academic impact, for papers by Tessa Y. S. Le Large Breakdown of academic impact, for papers by Marcela Mrhalová Breakdown of academic impact, for papers by Hideaki Takasaki Breakdown of academic impact, for papers by Woo Sun Kwon Breakdown of academic impact, for papers by Julia Ketzer Breakdown of academic impact, for papers by Yongping Xu
Rankless by CCL
2026